Skip to main content
. 2024 May 28;42(23):2790–2799. doi: 10.1200/JCO.23.01462

FIG A1.

FIG A1.

TTD in (A) cognitive functioning, (B) emotional functioning, and (C) social functioning. HRs were calculated versus sorafenib. HR, hazard ratio; NR, not reached; STRIDE, Single Tremelimumab Regular Interval Durvalumab; TTD, time to deterioration.